Trial of T-cell therapy for lung cancer begins at UCLH 

25/06/2020 00:00 
A UCLH patient  has received T-cell therapy for advanced lung cancer in a world first.
 

The innovative and personalised therapy – developed by the biopharmaceutical company Achilles Therapeutics – involves the collection of a patient’s blood and tumour samples in order to manufacture individual patient tumour-specific T-cells. These T-cells are then infused into the blood to seek out and eliminate cells in the tumour known as ‘clonal neoantigens’.

Researchers say the clonal neoantigen T-cell (cNeT) therapy has the potential to transform the treatment of cancer.

For the CHIRON study led by Dr Martin Forster, a Consultant Medical Oncologist at UCLH who is supported by the NIHR biomedical research centre at UCLH, researchers will give the cNeT therapy as a single dose to up to 40 patients who have advanced non-small cell lung cancer (NSCLC) – where the 5-year survival rate is just 5%.

They will first be looking at whether the treatment is safe and tolerable for patients, whilst monitoring to see if the treatment reduces tumour size and can improve survival. The study is taking place at sites across the UK.

NSCLC is responsible for 80% of all lung cancer cases. Lung cancer is the most common cause of cancer-related death worldwide with over 1.6 million deaths per year.

Dr Forster said: “We have been working closely with the Achilles team to design and set up this study across the UK, and are delighted to be dosing the first non-small cell lung cancer patient with this innovative experimental cell therapy here at UCLH, the lead clinical site.”

Dr Iraj Ali, CEO of Achilles Therapeutics, said: “NSCLC remains one of the most prevalent and poorly served of the solid tumours. The CHIRON study is an entirely personalised cell therapy designed to be exquisitely specific and effective and has the potential to help us fundamentally change how certain cancers are treated.”

 Latest news

 Contact details

Communications unit
2nd floor central
250 Euston Road
London NW1 2PG

Media enquiries

Switchboard: 020 3456 7890
Media enquiries: 020 3447 7542 / 020 3447 9506
Email: uclh.media@nhs.net

Out of hours
The normal working hours for the Communications Unit are Monday to Friday 9am – 5pm. The only media enquiries that will be answered outside of these working hours are urgent enquiries and those relating to major incidents. To access the out-of-hours service call switchboard on 0845 155 5000.

Share this story